A High Neutrophil-Lymphocyte Ratio Is Associated With Increased Morbidity and Mortality in Patients With Coronavirus Disease 2019

Supplemental Digital Content is available in the text. Objectives: The neutrophil-lymphocyte ratio is an inexpensive and simple inflammatory marker. A higher ratio, indicative of an acute hyperinflammatory response or diminished overall physiologic health status, has been associated with poor prognoses. This study aimed to evaluate the prognostic potential of admission neutrophil-lymphocyte ratio in patients admitted to the medical ICU with coronavirus disease 2019. Design: Retrospective review of prospectively collected data. Setting: Medical ICU from a large medical center. Patients: 2,071 consecutive patients admitted to the medical ICU with laboratory-confirmed severe acute respiratory syndrome coronavirus-2 between March 15, 2020, and December 30, 2020, were grouped by neutrophil-lymphocyte ratio above or below the median (7.45) at the time of hospital admission. Interventions: Complete blood count with differential at the time of hospital admission. Measurements and Main Results: A neutrophil-lymphocyte ratio above 7.45 at the time of hospital admission was associated with increased need for mechanical ventilation (45.8% vs 38.0%, p < 0.0001), vasopressor therapy (55.6% vs 48.2%, p = 0.001), and decreased survival through 180 days (54.8% vs 67.0%, p < 0.0001). Patients with a high neutrophil-lymphocyte ratio exhibited a 1.32 (95% CI, 1.14–1.54) times greater risk of mortality than those with a low neutrophil-lymphocyte ratio. Conclusions: The neutrophil-lymphocyte ratio at the time of hospital admission is an independent risk factor for morbidity and mortality. This prognostic indicator may assist clinicians appropriately identify patients at heightened risk for a severe disease course and tailor treatment accordingly.

[1]  Chengliang Zhu,et al.  Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19 , 2020, Frontiers in Molecular Biosciences.

[2]  Jian-Ping Liu,et al.  The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients , 2020, International Immunopharmacology.

[3]  Yan Zhao,et al.  Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 , 2020, Journal of Infection.

[4]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[5]  Z. Tian,et al.  Functional exhaustion of antiviral lymphocytes in COVID-19 patients , 2020, Cellular & Molecular Immunology.

[6]  Chuan Qin,et al.  Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Schmaier,et al.  Elevated neutrophil-lymphocyte ratio predicts mortality following elective endovascular aneurysm repair. , 2019, Journal of vascular surgery.

[8]  S. Clarke,et al.  The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. , 2013, Critical reviews in oncology/hematology.

[9]  S. Mirza,et al.  Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population , 2012, International archives of medicine.

[10]  G. Hillis,et al.  Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. , 2007, American heart journal.

[11]  M. ChB.,et al.  Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer , 2005, Journal of surgical oncology.